Article
The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.
The Canadian journal of cardiology - 1 Nov 2015
Morales Ana, Hershberger Ray E
Abstract excerpt
The genetic evaluation of dilated cardiomyopathy (DCM) has been challenging, owing in large part to marked genetic heterogeneity. However, lower costs from next-generation sequencing have enabled gene discovery and the expansion of genetic testing panels. These advances have improved molecular diagnostics and predictive testing in DCM. We provide a rationale and recommendation for clinical genetic testing in all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
